ADALIMUMAB

Adalimumab 20 mg/0.2 mL injection, 0.2 mL syringe

ADALIMUMAB (15565F)

Adalimumab 20 mg/0.2 mL injection, 0.2 mL syringe
15565F
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Vision threatening non-infectious uveitis
Treatment phase: Initial treatment

Restriction

Indication: Vision threatening non-infectious uveitis
Treatment phase: Recommencement of treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 6 DPMQ: $606.96 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Amgevita